The Paycheck Protection Program (PPP), which has provided loans to small businesses (some of which need not be paid back) to help weather the COVID-19 pandemic, still has $130 billion of unspent funds. The deadline to apply for those funds…

The number of COVID-19 cases across more than half of the United States continues to rise.

The price for a 5-day course of the antiviral drug remdesivir—which has shown to reduce hospital stays for patients with severe COVID-19 illness—is $2,340. This cost is less than the $5,080 price tag recommended by the Institute for…

The World Health Organization states that AstraZeneca’s COVID-19 vaccine is leading the pack, with Moderna’s version a close second. Developed at Britain’s Oxford University, the AstraZeneca vaccine is already undergoing human trials. The…

As case numbers spike across the Sun Belt, the United States Centers for Disease Control and Prevention (CDC) has added to the list of those populations who are at high risk of COVID-19. First, the age threshold that initially listed adults…

The Small Business Personal Protective Equipment (PPE) Tax Credit Act HR 7216 has been introduced by a bipartisan coalition to provide small businesses with a $25,000 tax credit for purchasing the PPE required to reopen. The bill—sponsored…

While the United States struggles to contain the COVID-19 pandemic, dentistry continues its recovery, according to a new poll by the American Dental Association Health Policy Institute. Taken during the week of June 15, the poll shows that…

The United States Food and Drug Administration recently released a statement advising against the use of hand sanitizer manufactured by Mexico-based Eskbiochem SA de CV.

Terri Patrick, RDH, MS, CHES—an orofacial myofunctional therapist—is blogging for Dimensions of Dental Hygiene about COVID-19. Returning to clinical practice has left many oral health professionals wondering if they can get…

Clinical trials on an inhaled type of the antiviral treatment remdesivir will start on patients with COVID-19 beginning in August. Phase 1 trials on healthy volunteers will begin the week of June 22. Made by Gilead Sciences Inc, remdesivir…